American CryoStem Corporation Announces Name Change to ACS Global, Inc.
June 15 2011 - 9:00AM
Marketwired
American CryoStem Corporation (PINKSHEETS: AMCY) announced today
that at the open of business June 15, 2011, the name change of
American CryoStem Corporation to ACS Global, Inc. will take effect.
The Company will retain its current symbol AMCY.PK.
Mr. Anthony Dudzinski, CEO, stated, "We are excited to complete
this name change as the final step in our transaction with R &
A Productions, Inc. ACS Global will continue to explore
opportunities globally to secure and expand its position within the
stem cell and regenerative medicine industry."
About ACS Global, Inc.: ACS Global, Inc.
is the controlling shareholder of American CryoStem Corporation,
and develops new technologies internally and through strategic
relationships in the rapidly developing regenerative medicine and
stem cell industry.
The Private Securities Litigation Reform Act of 1995 provides a
"safe harbor" for forward-looking statements. Certain of the
statements contained herein, which are not historical facts, are
forward-looking statements with respect to events, the occurrence
of which involve risks and uncertainties. These forward-looking
statements may be impacted, either positively or negatively, by
various factors. Information concerning potential factors that
could affect the Company is detailed from time to time in the
Company's reports filed with the Securities and Exchange
Commission.
For More Information, contact: Investor Relations American
CryoStem Corporation 188 East Bergen Place, Suite 204 Red Bank, NJ
07701 Phone:732-747-1007 Fax: 732-747-7782
www.americancryostem.com
ACS Global (CE) (USOTC:AMCY)
Historical Stock Chart
From May 2024 to Jun 2024
ACS Global (CE) (USOTC:AMCY)
Historical Stock Chart
From Jun 2023 to Jun 2024